Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Incyte synthesizes CDK2/cyclin E inhibitors

Nov. 26, 2020

Constellation Pharmaceuticals synthesizes TREX1 inhibitors

Nov. 26, 2020

Kinnate Biopharma patents Raf kinase inhibitors

Nov. 26, 2020

Final phase I/II data for PLX-9486 plus sunitinib in GIST

Nov. 25, 2020

Snap Bio presents new Pim-1 and/or Pim-3 kinase inhibitors

Nov. 25, 2020

Incyte discloses new CDK2/cyclin E inhibitors

Nov. 25, 2020

Cure Biopharma patents gemcitabine prodrugs for cancer

Nov. 25, 2020

Making exceptional responders unexceptional

Nov. 25, 2020

BCL6 degrader works via combine and conquer strategy

Nov. 24, 2020

Onconova files IND application with FDA for ON-123300

Nov. 24, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...